Writing Exercise #2

As a healthcare professional, I would recommend my colleague to concentrate on HPV 16, 18, 31, and 35 for whichhuman papillomavirus (HPV) strains that should be covered in a new treatment. According to the article, “Viruses and Human Cancer: From Detection to Causality,” there has been over 100 types of human papillomavirus (HPV) discovered, several connected to human cancer. HPV is now recognized as the cause of all causes of cervical cancer in women, HPV strains 16, 18, 31, and 45 make up approximately 80% of cervical cancer cases. It is mentioned in the article that HPV types 33, 35, 39, 51 52, 56 58 and 59 are also linked with cervical; however, it is only carcinogenic, meaning it is only hypothesized that these strains cause cervical cancer. The new treatment that covers for HPV 16, 18, 31, and 45 should be administered to early teens who are yet to be sexually active since HPV. Because HPV is spread through intimate skin to skin contact it is necessary to administer the vaccination around this age. Normally, there are 3 doses of the HPV vaccination; the second dose administered one to two months after the first dose and the third should be given six months after the first. Without insurance, the vaccination for HPV is approximately $250, according to Planned Parenthood. There are also several programs that allows people to get the vaccination at a low or no cost. However, knowing HPV is linked to cancer, it is important for people to receive the vaccination it services as protection from contracting HPV. Not being vaccinated against HPV, raises the likelihood of getting cancer—which is much costlier to treat than paying for the HPV vaccine.  

Print Friendly, PDF & Email

Leave a Reply

Your email address will not be published. Required fields are marked *